(redirected from differentially)
Also found in: Dictionary, Thesaurus, Medical, Legal, Idioms, Encyclopedia.


A small charge added to the purchase price and subtracted from the selling price by the dealer for odd-lot quantities.


1. The degree of change in quality of the underlying asset on a futures contract that is allowed. Every futures contract specifies the quality of the commodity underlying it that must be delivered in order for the seller to fulfill the contract. The differential allows the seller to deliver a good of a different quality, at least within certain limits. Not all futures contracts allow for differentials.

2. A change in the location of delivery that some futures contracts allow the seller to make at his/her discretion.


1. In commodities trading, the premium or discount in the futures contract price caused by delivering a commodity that does not exactly meet the standards fixed by the exchange. Allowances for these differentials are included in the contract specifications.
References in periodicals archive ?
When RNA from in vivo microbial samples can be efficiently isolated and labeled, microarrays will provide substantial advantages over IVET and DFI technologies for identifying putative virulence factors, including immediate identification of differentially expressed genes and detection of temporal profiles of transcription induction and repression.
Vector products are capable of outputting five differentially corrected GPS positions per second, and 10 heading information corrections per second.
To identify differentially regulated genes, the 11 reference genes were numerically ranked with respect to each other within a treatment.
The genes of these clusters were identified as being differentially expressed as a direct result of griseofulvin exposure rather than subsequent pathologic change in the liver by two further observations.
The differentially regulated genes identified by SAGE in this analysis were validated in additional lung tumors using a variety of molecular biology techniques.
Megaclone(TM) technology is the foundation for Lynx's analytical applications, including: Massively Parallel Signature Sequencing, or MPSS(TM), technology, which provides gene sequence information and high-resolution gene expression data; Megasort(TM) technology, which provides differentially expressed gene sets; and Megatype(TM) technology, which is expected to provide single nucleotide polymorphism, or SNP, disease- or trait-association information.
The search for candidate biosynthetic genes will employ our Megasort(TM) technology, which we believe is ideally suited to identify novel differentially expressed genes in diverse plant species where little or no prior gene sequence information is available.
The Profiler module labels mass, retention time and abundance of two samples to identify peptides that are differentially up- or down-regulated.
These statements include those related to the identification of differentially expressed genes or SNPs, as well as the potential success of collaboration arrangements.
This novel technology enables true quantitative proteomics of three independent proteomes using Isotope Coded Protein Labels (ICPL), resulting in the identification of differentially expressed proteins in triplex analysis with an unmatched dynamic range due to the optional combination with intact protein fractionation steps.
These collaborations all feature the application of Lynx's Megasort(TM) technology to uncover differentially expressed genes in several important research areas.

Full browser ?